EYEGATE PHARMACEUTICALS INC's ticker is EYEGW and the CUSIP is 30233M115.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $2,000 | +100.0% | 35,621 | +89.8% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 18,771 | -9.4% | 0.00% | – |
Q4 2019 | $1,000 | – | 20,718 | -44.4% | 0.00% | – |
Q3 2019 | $0 | – | 37,292 | -64.8% | 0.00% | – |
Q2 2019 | $0 | – | 105,846 | +631.7% | 0.00% | – |
Q1 2019 | $0 | -100.0% | 14,465 | -69.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 46,644 | +261.6% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 12,900 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | +100.0% | 12,900 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | -50.0% | 12,900 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | -50.0% | 12,900 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | – | 12,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 137,092 | $7,000 | 0.00% |
CVI Holdings, LLC | 12,900 | $0 | 0.00% |
UBS Group AG | 4,300 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |